Yasuo Shimizu Selected Research

N-gamma-glutamylcysteine ethyl ester

9/2007

Glutathione redox regulates airway hyperresponsiveness and airway inflammation in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuo Shimizu Research Topics

Disease

14	Asthma (Bronchial Asthma) 11/2020 - 02/2005
5	Inflammation (Inflammations) 01/2019 - 07/2006
4	Idiopathic Pulmonary Fibrosis 11/2021 - 01/2006
4	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2020 - 01/2006
4	Gastroesophageal Reflux (GERD) 09/2009 - 07/2006
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2008 - 04/2007
2	Disease Progression 01/2022 - 01/2006
2	Obesity 01/2020 - 04/2019
2	Pleural Effusion (Pleural Effusions) 01/2018 - 12/2012
2	Tuberculosis (Tuberculoses) 11/2012 - 09/2006
2	Respiratory Hypersensitivity 03/2008 - 09/2007
1	Fibrosis (Cirrhosis) 03/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022
1	Adenocarcinoma of Lung 01/2022
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 12/2021
1	Communicable Diseases (Infectious Diseases) 06/2021
1	COVID-19 06/2021
1	Vector Borne Diseases 06/2021
1	Histiocytic Sarcoma 12/2020
1	Sarcoma (Soft Tissue Sarcoma) 12/2020
1	Pain (Aches) 12/2020
1	Hypersensitivity (Allergy) 11/2020
1	Idiopathic Interstitial Pneumonias 09/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 09/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 09/2020
1	Insulin Resistance 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Cardiomegaly (Heart Hypertrophy) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Dementia (Dementias) 04/2019
1	Hypertension (High Blood Pressure) 04/2019
1	Alzheimer Disease (Alzheimer's Disease) 04/2019
1	Pulmonary Tuberculosis 01/2018
1	Pleurisy (Pleuritis) 01/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2017
1	Granuloma 01/2015
1	Silicosis 01/2015
1	Lung Injury 01/2015
1	Pulmonary Alveolar Proteinosis 06/2011
1	Infections 08/2010
1	Pneumonia (Pneumonitis) 04/2009
1	Chronic Bronchitis 04/2009
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 04/2009

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 03/2016 - 09/2007
4	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2020 - 04/2009
3	Immunoglobulin E (IgE)IBA 11/2020 - 03/2008
3	Interleukin-13IBA 01/2017 - 03/2008
3	8-epi-prostaglandin F2alphaIBA 09/2009 - 01/2007
3	Proton Pump InhibitorsIBA 11/2007 - 07/2006
3	AcidsIBA 11/2007 - 07/2006
2	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 04/2007
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 05/2020 - 04/2009
2	IronIBA 01/2015 - 06/2011
2	Interleukin-12 (IL 12)IBA 08/2010 - 09/2007
2	CollagenIBA 04/2009 - 01/2006
2	Gemcitabine FDA Link 09/2008 - 03/2008
2	Lansoprazole (Prevacid)FDA LinkGeneric 01/2007 - 07/2006
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	amrubicinIBA 01/2022
1	PlatinumIBA 01/2022
1	130-nm albumin-bound paclitaxelIBA 01/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	pirfenidoneIBA 11/2021
1	nintedanibIBA 11/2021
1	VaccinesIBA 06/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020
1	Ifosfamide FDA LinkGeneric 12/2020
1	Dermatophagoides pteronyssinus antigen p 1IBA 11/2020
1	Dermatophagoides pteronyssinus antigen p 2IBA 11/2020
1	AntibodiesIBA 09/2020
1	vilanterolIBA 05/2020
1	Budesonide (Pulmicort)FDA LinkGeneric 05/2020
1	Formoterol Fumarate (Oxis)FDA Link 05/2020
1	fluticasone furoate FDA Link 05/2020
1	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 05/2020
1	LipidsIBA 01/2020
1	Catechin (Z 7300)IBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	TeaIBA 01/2020
1	Pharmaceutical PreparationsIBA 04/2019
1	CholesterolIBA 04/2019
1	SteroidsIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2019
1	Adenosine DeaminaseIBA 01/2018
1	Fibronectins (Fibronectin)IBA 03/2016
1	Proteins (Proteins, Gene)FDA Link 03/2016
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2015
1	AA amyloidosisIBA 12/2012
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2012
1	CC ChemokinesIBA 01/2012
1	CCR1 ReceptorsIBA 01/2012

Therapy/Procedure

9	Therapeutics 03/2022 - 02/2005
5	Drug Therapy (Chemotherapy) 01/2022 - 04/2007
1	Early Ambulation 12/2021
1	Radiotherapy 12/2020
1	Immunotherapy 11/2020
1	Immunomodulation 01/2012